Stay updated with breaking news from William Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Semaglutide is not associated with an increased risk for suicidal ideation compared with non-glucagon-like peptide 1 receptor (GLP1R) agonist antiobesity medications.
The clinics have greatly reduced the number of patients landing in the emergency room because of uncontrolled symptoms, and patient success stories abound.
For individuals with overweight or obesity and type 2 diabetes, semaglutide is not associated with an increased risk for suicidal ideation.
Entrepreneurs often describe their business challenges as matters of life and death. William Wang has a different relationship with that phrase. Back in 2000,…
<p>A groundbreaking study by researchers at Case Western Reserve University suggests a class of medications used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC). The findings, published today (Dec. 7) in the journal <em>JAMA Oncology</em>,<em> </em>support the need for clinical trials to determine whether these medications could prevent one of the deadliest types of cancers. Eventually, the medications may also show promise in warding off other types of cancer associated with obesity and diabetes.</p>